Last reviewed · How we verify
NCT03707132
Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
trial testing Tourniquet: Folley catheter in the low segment of the uterus in Placenta Accreta in 43 participants. Completed in 30 September 2017.
30 September 2017
Quick facts
| Lead sponsor | University Tunis El Manar |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 43 |
| Start date | 1 October 2014 |
| Primary completion | 30 September 2017 |
| Estimated completion | 30 September 2017 |
Drugs / interventions tested
- Tourniquet: Folley catheter in the low segment of the uterus
Conditions studied
- Placenta Accreta — all drugs for Placenta Accreta →
- Post Partum Hemorrhage — all drugs for Post Partum Hemorrhage →
- Blood Loss Massive — all drugs for Blood Loss Massive →
Sponsor
University Tunis El Manar
Who can join
Eligibility, female only, with Placenta Accreta or Post Partum Hemorrhage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Monocentric prospective observational study comparing the use of tourniquet in low uterus segement versus standard procedure in hysterectomy owing to placenta accreta
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Tourniquet on the low segment of the uterus reduces blood loss in postpartum hemorrhage during hysterectomy for placenta accreta: Old but gold.
Abouda HS, Marzouk SB, Boussarsar Y, Aloui H, et al · · 2024 · cited 4× · PMID 38351966 · DOI 10.1016/j.eurox.2024.100285
Verify or expand the search:
- PubMed search for NCT03707132
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Placenta Accreta
Currently open trials in the same condition.
- NCT07283042 — Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum · recruiting
- NCT06465836 — Simplified Conservative Measures in Managing Morbidly Adherent Placenta in Beni-Suef University · NA · recruiting
- NCT06185894 — Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery · NA · recruiting
- NCT06833606 — Diagnosis and Outcomes of Placental Accretism · recruiting
- NCT05922397 — Placenta Accreta Spectrum Topographic Classification · recruiting
Other University Tunis El Manar trials
Trials by the same sponsor.
- NCT07467967 — Impact of Date Consumption on Metabolic Control and Oxidative Stress in Patients With Type 2 Diabetes · NA · not yet recruiting
- NCT07378904 — Sterile Water Injection vs Morphine for Renal Colic · NA · active not recruiting
- NCT07313553 — Prevention of Rebound Pain After Axillary Block · NA · not yet recruiting
- NCT07240961 — Lumbal Erector Spinae Plane Block for Pain Management After Total Hip Arthroplasty · NA · recruiting
- NCT07194967 — Virtual Reality for Pain and Anxiety Relief in Labor · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03707132 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Tunis El Manar
- Last refreshed: 16 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03707132.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing